*Based on the number of new MS prescriptions for the months December 2020 through November 2021 per IQVIA NPA New to Brand, Patient Insights® monthly NBRx.
VUMERITY® (diroximel fumarate) is a prescription medicine used to treat people with relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease in adults. It is not known if VUMERITY is safe and effective in children.
See more below
Find out how VUMERITY may be covered with the Biogen Copay Program.
Watch how VUMERITY may help with treatment goals.
Check out the three steps to take before starting on treatment.
Get the latest information about relapsing MS and VUMERITY. Sign up to get a free brochure, our newsletters, and personalized support through Biogen Support Services.
Please enter a valid email address.
Thank you for your response.You may find it helpful to explore how others like you feel about VUMERITY® (diroximel fumarate).
Thank you for your response. We always like hearing from you!